BKL and Greenberg Traurig advised NeoImmuneTech, Inc. on the deal. NeoImmuneTech, Inc., a US Delaware corporation engaged in the biotech business, successfully consummated its Korean IPO...
This content is for Standard 1 Year members only. LoginJoin Now